


Antegenes is an innovation-oriented Estonian medical laboratory and technology company founded in 2018.

We develop and implement advanced genetic tests based on polygenic risk scores technology for major complex diseases (cancer and cardiovascular diseases) to enable personalised prevention measures and programs. Antegenes products are created scientifically with laboratory and clinical validity and clinical usefulness, which makes these usable in healthcare by a broad range of healthcare professionals and institutions.

Antegenes’ mission is to enable people to have a better, healthier, and longer life by helping individuals, healthcare professionals, and organisations use genetic information for personal and public health.

Our cancer tests